Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: Ramadan


Impact of Ramadan‐focused diabetes education on hypoglycemia risk and metabolic control for patients with type 2 diabetes mellitus: A systematic review

December 8th 2020

Ramadan‐focused diabetes education had a significant impact on hypoglycemia and glycaemic control, with no significant effect on body weight, blood lipids or blood pressure (International Journal of Clinical Practice)

Categories: Education, News
Tags: hypoglycemia, Ramadan, Type 2 Diabetes

Categories: Education
Tags: hypoglycemia, Ramadan, Type 2 Diabetes

Efficacy and Safety of the Newer Oral Hypoglycemic Agents in Patients with T2DM During Ramadan: A Systematic Review and Meta-analysis

November 30th 2020

This systematic review and meta-analysis shows clinical benefits with the glucose lowering medications in patients with T2DM who fast during Ramadan (Diabetes Research and Clinical Practice)

Categories: Medication, News
Tags: Ramadan, Type 2 Diabetes

Categories: Medication
Tags: Ramadan, Type 2 Diabetes

Diabetes and Ramadan: utility of flash-glucose monitoring derived markers of glycaemic control and comparison with glycosylated haemoglobin

May 29th 2019

Ramadan fasting was associated with was a deterioration in overall glucose control and time in hyperglycaemia in insulin-treated patients. FGM-derived markers are useful and a preferable alternative to HbA1c in Ramadan studies (Diabetes Research and Clinical Practice)

Categories: Monitoring, News
Tags: Flash, Ramadan

Categories: Monitoring
Tags: Flash, Ramadan

The incidence of diabetic ketoacidosis during Ramadan fasting: a 10-year single-centre retrospective study

January 25th 2019

The present study confirmed that DKA admissions during Ramadan were not significantly higher than the average monthly admissions over ten years. Seasonality trends were not related to Ramadan (Diabetes Research and Clinical Practice)

Categories: News, Prevalence
Tags: Ketoacidosis, Ramadan

Categories: Prevalence
Tags: Ketoacidosis, Ramadan

Diabetes, driving and fasting during Ramadan: the interplay between secular and religious law

June 4th 2018

Ultimately further research on glycemic control and management when fasting and driving, as well as a formal legal guidance on this topic, is required to safeguard healthcare professionals and the public from the potential dangers of driving with diabetes and fasting (BMJ)

Categories: Diet, News
Tags: driving, Ramadan

Categories: Diet
Tags: driving, Ramadan

Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting

March 15th 2017

In patients with T1DM who fast Ramadan, there was no difference in rates of hypoglycemia or hyperglycemia between CSII and MDI. However, CSII was associated with less glucose variability (Diabetes Technology and Therapeutics)

Categories: Management, News
Tags: fasting, Ramadan, Type 1 Diabetes

Categories: Management
Tags: fasting, Ramadan, Type 1 Diabetes

Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study

August 25th 2016

Treatment with vildagliptin was associated with lower incidence of hypoglycemia compared with SU and showed good glycemic and weight control in patients with T2DM fasting during Ramadan in a real-life setting in Egypt (Diabetes Therapy)

Categories: Management, News
Tags: Ramadan, sulfonylureas, Type 2 Diabetes, vildagliptin

Categories: Management
Tags: Ramadan, sulfonylureas, Type 2 Diabetes, vildagliptin

Diabetes and Ramadan practical guidelines

May 10th 2016

The IDF-DAR Practical Guidelines provide healthcare professionals (HCPs) with relevant background information and practical recommendations to enable them to help people with diabetes participate in fasting during Ramadan while minimising the risk of complications

Categories: Management, News
Tags: Ramadan

Categories: Management
Tags: Ramadan

Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence

April 18th 2016

More rigorous studies using trial designs suited to the unique conditions of a fasting population and capturing both standardized efficacy and safety end points are needed to provide better guidance to optimal treatment of T2D during Ramadan fasting (Diabetes Therapy)

Categories: Management, News
Tags: Ramadan

Categories: Management
Tags: Ramadan

New study with Victoza® (liraglutide) showed improvements in blood glucose control in adults with type 2 diabetes who fasted during Ramadan

June 8th 2015

New findings showed that adults with type 2 diabetes treated with Victoza®, in combination with metformin, experienced similar improvements in blood glucose control while fasting during Ramadan (four weeks) compared with sulfonylurea (SU) plus metformin (Novo Nordisk)

Categories: Medication, News
Tags: Ramadan, Victoza

Categories: Medication
Tags: Ramadan, Victoza

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Napp DiabetesAstraZenecaBoehringer IngelheimNovo Nordisk

Silver Sponsors

About Ascensia Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes β-cell

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership